Potassium canrenoate

Potassium canrenoate
Systematic (IUPAC) name
	potassium 3-[(8R,9S,10R,13S,14S,17R)-; 17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,; 11,12,14,15,16-octahydro-1H-cyclopenta[a]; phenanthren-17-yl]propanoate
Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy cat.	?
Legal status	?
Routes	Intravenous
Pharmacokinetic data
Metabolism	Hepatic
Excretion	Renal and fecal
Identifiers
CAS number	2181-04-6
ATC code	C03DA02
PubChem	CID 656614
ChemSpider	570975
UNII	M671F9NLEA
Chemical data
Formula	C22H29KO4
Mol. mass	369.516 g/mol
SMILES	eMolecules & PubChem
	InChI InChI=1S/C22H30O4.K/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21,26)12-8-19(24)25;/h3-4,13,16-18,26H,5-12H2,1-2H3,(H,24,25);/q;+1/p-1/t16-,17+,18+,20+,21+,22-;/m1./s1 ; Key:JTZQCHFUGHIPDF-RYVBEKKQSA-M ;
(what is this?) (verify);

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Potassium canrenoate (INN) or canrenoate potassium (USAN), the potassium salt of canrenoic acid, is an aldosterone antagonist.

Like spironolactone, it is a prodrug, which is metabolized to canrenone in the body.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.


Systematic (IUPAC) name
potassium 3-[(8R,9S,10R,13S,14S,17R)- 17-hydroxy-10,13-dimethyl-3-oxo-2,8,9, 11,12,14,15,16-octahydro-1H-cyclopenta[a] phenanthren-17-yl]propanoate
Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy cat.	?
Legal status	?
Routes	Intravenous
Pharmacokinetic data
Metabolism	Hepatic
Excretion	Renal and fecal
Identifiers
CAS number	2181-04-6^N
ATC code	C03DA02
PubChem	CID 656614
ChemSpider	570975^Y
UNII	M671F9NLEA^N
Chemical data
Formula	C₂₂H₂₉K O₄
Mol. mass	369.516 g/mol
SMILES	eMolecules & PubChem
InChI InChI=1S/C22H30O4.K/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21,26)12-8-19(24)25;/h3-4,13,16-18,26H,5-12H2,1-2H3,(H,24,25);/q;+1/p-1/t16-,17+,18+,20+,21+,22-;/m1./s1^Y Key:JTZQCHFUGHIPDF-RYVBEKKQSA-M^Y
N (what is this?) (verify)